Centrul de Evaluare și Tratament a Toxicodependenței pentru Tineri Sf.Stelian

The trials here

What the 2 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease2 trials

Phase

• Phase 32 trials

Status

• Not yet recruiting1 trial
• Recruiting1 trial

Lead sponsor

• Bristol-Myers Squibb2 trials

Running trials

• Recruiting

  A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

  NCT06937229· Phase 3· Bristol-Myers Squibb· Source

• Recruiting

  A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Alzheimer's Disease (ADAGIO-1)

  NCT07011732· Phase 3· Bristol-Myers Squibb· Source

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Alzheimer disease2 recruiting